Insider Trading activities of Intercept Pharmaceuticals Inc insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Intercept Pharmaceuticals Inc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Intercept Pharmaceuticals Inc since year 2005. Table 2 shows the detailed insider transactions of Intercept Pharmaceuticals Inc since 2005. The reporting company's ticker symbol is ICPT. The reporting company's CIK number is 1270073.
The total value of stock buying since 2005 is $20,941,980.
The total value of stock sales since 2005 is $1,109,674,824.
The total value of stock option exercises since 2005 is $9,709,295.


 1   2   3 
Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Intercept Pharmaceuticals Inc (ICPT).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2017-10 0 $0 2,956 $174,002 0 $0
2017-09 0 $0 1,250 $146,787 1,250 $39,875
2017-08 0 $0 1,513 $176,865 1,118 $9,689
2017-07 0 $0 5,507 $674,400 0 $0
2017-06 0 $0 40,698 $5,331,297 40,000 $346,680
2017-05 0 $0 2,024 $230,135 1,117 $9,681
2017-04 0 $0 1,551 $174,737 0 $0
2017-03 0 $0 2,799 $362,296 1,350 $29,025
2017-02 0 $0 254 $30,347 0 $0
2017-01 0 $0 7,424 $775,439 0 $0
2016-12 0 $0 6,750 $673,310 3,487 $93,102
2016-11 0 $0 389 $44,004 0 $0
2016-10 0 $0 3,060 $490,150 1,350 $29,025
2016-09 0 $0 38,545 $6,361,325 35,000 $323,575
2016-08 0 $0 371 $61,184 0 $0
2016-07 0 $0 1,284 $186,316 12,500 $122,774
2016-05 0 $0 381 $53,684 1,500 $32,250
2016-04 0 $0 1,274 $166,587 0 $0
2016-02 0 $0 369 $41,023 0 $0
2016-01 0 $0 4,324 $616,048 7,789 $0
2015-12 0 $0 3,500 $550,952 14,926 $266,726
2015-11 0 $0 11,012 $2,067,881 8,973 $91,724
2015-10 0 $0 3,335 $558,549 11,660 $46,398
2015-09 0 $0 4,973 $957,247 10,267 $96,523
2015-08 0 $0 5,746 $1,226,484 4,974 $50,650
2015-07 0 $0 24,092 $7,534,115 33,399 $218,236
2015-06 0 $0 8,865 $2,190,379 15,426 $181,933
2015-05 0 $0 27,646 $7,536,186 27,364 $256,136
2015-04 0 $0 9,020 $2,460,323 16,136 $77,784
2015-03 0 $0 740,864 $208,708,166 9,864 $97,697
2015-02 0 $0 6,485 $1,368,642 10,633 $111,996
2015-01 0 $0 21,341 $4,197,264 27,991 $489,095
2014-12 800 $111,888 233 $33,589 233 $5,009
2014-11 2,000 $330,072 15,023 $3,360,074 23,449 $288,326
2014-10 0 $0 16,411 $3,786,781 24,152 $138,727
2014-09 0 $0 14,391 $4,116,543 14,391 $136,676
2014-08 0 $0 390,080 $116,370,634 45,533 $631,999
2014-07 0 $0 17,428 $4,310,652 25,155 $121,749
2014-06 0 $0 14,000 $3,416,386 14,000 $128,270
2014-05 0 $0 19,902 $5,249,836 26,286 $217,057
2014-04 0 $0 1,229,111 $390,086,248 56,550 $367,522
2014-03 0 $0 26,456 $11,462,255 30,917 $867,336
2014-02 0 $0 15,548 $5,648,366 15,281 $125,792
2014-01 0 $0 27,276 $5,678,138 37,490 $398,959
2013-12 0 $0 5,276 $325,984 25,253 $101,122
2013-11 0 $0 6,892 $337,090 7,786 $59,800
2013-10 0 $0 4,585,390 $286,627,185 15,981 $59,800
2013-09 0 $0 40,100 $2,060,521 43,250 $428,123
2013-08 0 $0 29,029 $1,343,067 23,379 $217,568
2013-07 0 $0 93,869 $4,422,098 102,013 $919,221
2013-06 0 $0 95,091 $3,440,061 93,825 $895,688
2013-05 0 $0 39,441 $1,344,579 39,839 $518,290
2013-04 0 $0 3,750 $128,613 49,917 $61,687
2012-10 1,366,668 $20,500,020 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Intercept Pharmaceuticals Inc insiders (ICPT)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2017-10-02 Kim Richard J (SVP, Commercial US) Sale 48 58.10 2,788
2017-10-02 Kapadia Sandip (Chief Financial Officer) Sale 354 58.83 20,826
2017-10-02 Bright Lisa (President International) Sale 390 58.92 22,979
2017-10-02 Mcminn Rachel (Chief Strategy Officer) Sale 283 58.89 16,666
2017-10-02 Shapiro David (CMO and EVP - Development) Sale 349 58.90 20,555
2017-10-02 Pruzanski Mark (CEO & President) Sale 1,532 58.87 90,188
2017-09-01 Shapiro David (CMO and EVP - Development) Sale 1,250 117.43 146,787
2017-09-01 Shapiro David (CMO and EVP - Development) Option Ex 1,250 31.90 39,875
2017-08-25 Bright Lisa (President International) Sale 253 111.32 28,163
2017-08-02 Bright Lisa (President International) Sale 142 110.29 15,660
2017-08-01 Shapiro David (CMO and EVP - Development) Sale 1,118 119.00 133,042
2017-08-01 Shapiro David (CMO and EVP - Development) Option Ex 1,118 8.67 9,689
2017-07-31 Mcminn Rachel (Chief Strategy Officer) Sale 130 123.12 16,005
2017-07-31 Welch Daniel G Sale 602 123.93 74,603
2017-07-20 Welch Daniel G Sale 217 126.76 27,506
2017-07-14 Kim Richard J (SVP, Commercial US) Sale 89 128.64 11,449
2017-07-11 Shapiro David (CMO and EVP - Development) Sale 553 124.01 68,577
2017-07-03 Kim Richard J (SVP, Commercial US) Sale 50 121.69 6,084
2017-07-03 Kapadia Sandip (Chief Financial Officer) Sale 1,431 121.59 173,999
2017-07-03 Bright Lisa (President International) Sale 394 121.33 47,802
2017-07-03 Mcminn Rachel (Chief Strategy Officer) Sale 257 121.78 31,297
2017-07-03 Shapiro David (CMO and EVP - Development) Sale 350 121.28 42,446
2017-07-03 Pruzanski Mark (CEO & President) Sale 1,434 121.78 174,632
2017-06-26 Pruzanski Mark (CEO & President) Sale 40,000 131.35 5,254,000
2017-06-26 Pruzanski Mark (CEO & President) Option Ex 40,000 8.67 346,680
2017-06-01 Bright Lisa (President International) Sale 698 110.74 77,297
2017-05-25 Bright Lisa (President International) Sale 254 117.52 29,850
2017-05-16 Bright Lisa (President International) Sale 113 119.66 13,521
2017-05-02 Bright Lisa (President International) Sale 426 114.00 48,564
2017-05-01 Mcminn Rachel (Chief Strategy Officer) Sale 114 113.12 12,895
2017-05-01 Shapiro David (CMO and EVP - Development) Sale 1,117 112.18 125,305
2017-05-01 Shapiro David (CMO and EVP - Development) Option Ex 1,117 8.67 9,681
2017-04-10 Shapiro David (CMO and EVP - Development) Sale 558 108.51 60,548
2017-04-03 Bright Lisa (President International) Sale 389 115.00 44,733
2017-04-03 Mcminn Rachel (Chief Strategy Officer) Sale 257 115.00 29,554
2017-04-03 Shapiro David (CMO and EVP - Development) Sale 346 115.00 39,788
2017-04-03 Pruzanski Mark (CEO & President) Sale 1 115.00 114
2017-03-02 Bright Lisa (President International) Sale 1,313 130.16 170,904
2017-03-01 Bright Lisa (President International) Sale 136 130.16 17,701
2017-03-01 Shapiro David (CMO and EVP - Development) Sale 1,350 128.66 173,691
2017-03-01 Shapiro David (CMO and EVP - Development) Option Ex 1,350 21.50 29,025
2017-02-27 Bright Lisa (President International) Sale 254 119.48 30,347
2017-01-31 Bright Lisa (President International) Sale 134 108.96 14,600
2017-01-09 Shapiro David (CMO and EVP - Development) Sale 1,565 106.01 165,905
2017-01-03 Bright Lisa (President International) Sale 1,119 103.92 116,285
2017-01-03 Mcminn Rachel (Chief Strategy Officer) Sale 816 103.92 84,797
2017-01-03 Shapiro David (CMO and EVP - Development) Sale 988 103.92 102,671
2017-01-03 Pruzanski Mark (CEO & President) Sale 2,802 103.92 291,181
2016-12-06 Pruzanski Mark (CEO & President) Option Ex 3,487 26.70 93,102
2016-12-02 Shapiro David (CMO and EVP - Development) Sale 4,050 99.75 403,986
2016-11-25 Bright Lisa (President International) Sale 249 113.60 28,286
2016-11-15 Bright Lisa (President International) Sale 140 112.27 15,718
2016-10-31 Mcminn Rachel (Chief Strategy Officer) Sale 129 123.82 15,972
2016-10-10 Shapiro David (CMO and EVP - Development) Sale 411 153.34 63,022
2016-10-03 Bright Lisa (See Remarks) Sale 155 163.20 25,296
2016-10-03 Shapiro David (CMO and EVP - Development) Sale 1,513 163.13 246,815
2016-10-03 Shapiro David (CMO and EVP - Development) Option Ex 1,350 21.50 29,025
2016-10-03 Pruzanski Mark (CEO & President) Sale 705 163.20 115,055
2016-10-03 Duncan Barbara Gayle (Chief Accounting Officer) Sale 147 163.20 23,990
2016-09-26 Shapiro David (CMO and EVP - Development) Sale 3,545 165.40 586,325
2016-09-20 Pruzanski Mark (CEO & President) Sale 35,000 165.00 5,775,000
2016-09-20 Pruzanski Mark (CEO & President) Option Ex 35,000 9.24 323,575
2016-08-25 Bright Lisa (President of International) Sale 246 159.00 39,114
2016-08-01 Mcminn Rachel (Chief Strategy Officer) Sale 125 176.56 22,070
2016-07-15 Pruzanski Mark (CEO & President) Option Ex 12,500 9.82 122,774
2016-07-05 Bright Lisa (See Remarks) Sale 155 145.11 22,491
2016-07-05 Mcminn Rachel (Chief Strategy Officer) Sale 106 145.11 15,381
2016-07-05 Shapiro David (CMO and EVP - Development) Sale 163 145.11 23,652
2016-07-05 Pruzanski Mark (CEO & President) Sale 714 145.11 103,607
2016-07-05 Duncan Barbara Gayle (Chief Accounting Officer) Sale 146 145.11 21,185
2016-05-25 Bright Lisa (See Remarks) Sale 251 137.50 34,511
2016-05-13 Akkaraju Srinivas Option Ex 1,500 21.50 32,250
2016-05-02 Mcminn Rachel (Chief Strategy Officer) Sale 130 147.49 19,173
2016-04-04 Bright Lisa (See Remarks) Sale 153 130.76 20,006
2016-04-04 Mcminn Rachel (Chief Strategy Officer) Sale 104 130.76 13,599
2016-04-04 Shapiro David (CMO and EVP - Development) Sale 165 130.76 21,575
2016-04-04 Pruzanski Mark (CEO & President) Sale 708 130.76 92,578
2016-04-04 Duncan Barbara Gayle (Chief Financial Officer) Sale 144 130.76 18,829
2016-02-25 Bright Lisa (See Remarks) Sale 241 115.22 27,768
2016-02-01 Mcminn Rachel (Chief Strategy Officer) Sale 128 103.56 13,255
2016-01-13 Bright Lisa (See Remarks) Sale 104 129.99 13,518
2016-01-12 Bright Lisa (See Remarks) Sale 624 124.78 77,862
2016-01-04 Mcminn Rachel (Chief Strategy Officer) Sale 469 145.90 68,428
2016-01-04 Shapiro David (CMO and EVP - Development) Sale 533 145.90 77,766
2016-01-04 Pruzanski Mark (CEO & President) Sale 2,126 145.90 310,191
2016-01-04 Duncan Barbara Gayle (Chief Financial Officer) Sale 468 145.90 68,283
2016-01-01 Shapiro David (CMO and EVP - Development) Option Ex 1,623 .00 0
2016-01-01 Pruzanski Mark (CEO & President) Option Ex 4,868 .00 0
2016-01-01 Duncan Barbara Gayle (Chief Financial Officer) Option Ex 1,298 .00 0
2015-12-18 Shapiro David (CMO and EVP - Development) Option Ex 11,426 20.69 236,392
2015-12-15 Shapiro David (CMO and EVP - Development) Sale 3,500 157.41 550,952
2015-12-15 Shapiro David (CMO and EVP - Development) Option Ex 3,500 8.67 30,334
2015-11-25 Bright Lisa (See Remarks) Sale 1,150 182.97 210,409
2015-11-20 Williams Nicole Sale 973 167.00 162,491
2015-11-20 Williams Nicole Option Ex 973 9.82 9,556
2015-11-16 Shapiro David (CMO and EVP - Development) Sale 4,264 178.75 762,177
2015-11-16 Shapiro David (CMO and EVP - Development) Option Ex 3,500 8.67 30,334
2015-11-10 Shapiro David (CMO and EVP - Development) Sale 3,500 204.15 714,525
2015-11-10 Shapiro David (CMO and EVP - Development) Option Ex 3,500 8.67 30,334
2015-11-10 Veitinger Klaus R Dr Sale 1,000 198.25 198,250
2015-11-10 Veitinger Klaus R Dr Option Ex 1,000 21.50 21,500
2015-11-02 Mcminn Rachel (Chief Strategy Officer) Sale 125 160.24 20,029
2015-10-28 Akkaraju Srinivas Option Ex 1,250 21.50 26,875
2015-10-20 Williams Nicole Sale 974 182.22 177,482
2015-10-20 Williams Nicole Option Ex 974 9.82 9,566
2015-10-02 Shapiro David (CMO and EVP - Development) Sale 858 159.04 136,455
2015-10-02 Pruzanski Mark (CEO & President) Sale 167 159.04 26,559
2015-10-02 Duncan Barbara Gayle (Chief Financial Officer) Sale 54 159.04 8,588
2015-10-01 Shapiro David (CMO and EVP - Development) Sale 282 163.39 46,075
2015-10-01 Shapiro David (CMO and EVP - Development) Option Ex 1,622 .00 0
2015-10-01 Pruzanski Mark (CEO & President) Option Ex 4,867 .00 0
2015-10-01 Adorini Luciano (Chief Scientific Officer) Option Ex 649 .00 0
2015-10-01 Duncan Barbara Gayle (Chief Financial Officer) Sale 1,000 163.39 163,390
2015-10-01 Duncan Barbara Gayle (Chief Financial Officer) Option Ex 2,298 4.33 9,957
2015-09-21 Williams Nicole Sale 973 194.82 189,559
2015-09-21 Williams Nicole Option Ex 973 9.82 9,556
2015-09-15 Shapiro David (CMO and EVP - Development) Sale 3,500 191.02 668,563
2015-09-15 Shapiro David (CMO and EVP - Development) Option Ex 8,794 8.67 76,217
2015-09-09 Veitinger Klaus R Dr Sale 500 198.25 99,125
2015-09-09 Veitinger Klaus R Dr Option Ex 500 21.50 10,750
2015-08-20 Williams Nicole Sale 974 206.85 201,471
2015-08-20 Williams Nicole Option Ex 974 9.82 9,566
2015-08-17 Shapiro David (CMO and EVP - Development) Sale 4,272 209.37 894,428
2015-08-17 Shapiro David (CMO and EVP - Development) Option Ex 3,500 8.67 30,334
2015-08-03 Veitinger Klaus R Dr Sale 500 261.17 130,585
2015-08-03 Veitinger Klaus R Dr Option Ex 500 21.50 10,750
2015-07-31 Mcminn Rachel (Chief Strategy Officer) Sale 127 262.09 33,285
2015-07-24 Fundaro Paolo Sale 582 285.00 165,870
2015-07-20 Williams Nicole Sale 973 279.01 271,476
2015-07-20 Williams Nicole Option Ex 973 9.82 9,556
2015-07-10 Pruzanski Mark (CEO & President) Sale 12,500 250.00 3,125,000
2015-07-10 Pruzanski Mark (CEO & President) Option Ex 12,500 8.67 108,337
2015-07-06 Adorini Luciano (Chief Scientific Officer) Sale 4,067 624.06 2,538,052
2015-07-06 Adorini Luciano (Chief Scientific Officer) Option Ex 4,067 15.08 61,342
2015-07-02 Shapiro David (CMO and EVP - Development) Sale 851 237.76 202,336
2015-07-02 Pruzanski Mark (CEO & President) Sale 158 237.76 37,566
2015-07-02 Duncan Barbara Gayle (Chief Financial Officer) Sale 53 237.76 12,601
2015-07-01 Shapiro David (CMO and EVP - Development) Sale 3,781 239.57 905,829
2015-07-01 Shapiro David (CMO and EVP - Development) Option Ex 5,123 4.33 30,334
2015-07-01 Pruzanski Mark (CEO & President) Option Ex 4,868 .00 0
2015-07-01 Adorini Luciano (Chief Scientific Officer) Option Ex 649 .00 0
2015-07-01 Duncan Barbara Gayle (Chief Financial Officer) Sale 1,000 242.10 242,100
2015-07-01 Duncan Barbara Gayle (Chief Financial Officer) Option Ex 2,298 4.33 8,667
2015-06-22 Williams Nicole Sale 974 265.14 258,246
2015-06-22 Williams Nicole Option Ex 974 9.82 9,566
2015-06-15 Shapiro David (CMO and EVP - Development) Sale 3,500 241.54 845,393
2015-06-15 Shapiro David (CMO and EVP - Development) Option Ex 3,500 8.67 30,334
2015-06-10 Veitinger Klaus R Dr Sale 391 238.21 93,140
2015-06-10 Veitinger Klaus R Dr Option Ex 391 21.50 8,406
2015-06-08 Adorini Luciano (Chief Scientific Officer) Sale 4,000 248.40 993,600
 1   2   3 

Insider trading activities including stock purchases, stock sales, and option exercises of ICPT listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Intercept Pharmaceuticals Inc (symbol ICPT, CIK number 1270073) see the Securities and Exchange Commission (SEC) website.